JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Tessa Romero has maintained an Overweight rating on Biohaven (NYSE:BHVN) and increased the price target from $26 to $32.
November 20, 2023 | 4:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst has reaffirmed an Overweight rating on Biohaven and raised the price target to $32, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like JP Morgan's Tessa Romero is a strong positive signal for investors, suggesting a higher valuation and potential upside for Biohaven's stock. This typically leads to increased investor confidence and can drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100